Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a

Updated on: April 07,2026

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a

Updated on:April 07,2026

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

by Lori SolomonLong-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a studypublishedonline Oct. 10 inSLEEPJ.Michael R. Irwin

Updated on: February 14,2026

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

by Lori SolomonLong-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a studypublishedonline Oct. 10 inSLEEPJ.Michael R. Irwin

Updated on:February 14,2026

Living longer with tailored chemotherapy—despite incurable cancer

by Anne Sliper Midling,Norwegian University of Science and TechnologyAll rapidly growing cells in the body are affected by chemotherapy. Cancer cells are targeted, but so are, for example, hair cells

Updated on: March 13,2026

Living longer with tailored chemotherapy—despite incurable cancer

by Anne Sliper Midling,Norwegian University of Science and TechnologyAll rapidly growing cells in the body are affected by chemotherapy. Cancer cells are targeted, but so are, for example, hair cells

Updated on:March 13,2026

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

byUniversity of Miami Leonard M. Miller School of Medicine"This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatment

Updated on: March 14,2026

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

byUniversity of Miami Leonard M. Miller School of Medicine"This triple therapy approach could be a game-changer for patients whose (breast) cancers no longer respond to standard hormone treatment

Updated on:March 14,2026

New international study reveals major survival gaps among children with cancer

byUniversity of BergenCountries with at least 25 childhood cancer cases included in the present study. Included countries are Algeria, Argentina, Bahrain, Brazil, Chile, China, Colombia, Costa Rica, E

Updated on: March 19,2026

New international study reveals major survival gaps among children with cancer

byUniversity of BergenCountries with at least 25 childhood cancer cases included in the present study. Included countries are Algeria, Argentina, Bahrain, Brazil, Chile, China, Colombia, Costa Rica, E

Updated on:March 19,2026

Tracking RNA levels reveals new clues in triple-negative breast cancer progression

by Jen A. Miller,Cold Spring Harbor LaboratoryMetastatic lesions had far higher levels ofMALAT1(pink) than the surrounding tissues. Credit: Spector lab/CSHLWhen researchers look for potential cancer t

Updated on: April 04,2026

Tracking RNA levels reveals new clues in triple-negative breast cancer progression

by Jen A. Miller,Cold Spring Harbor LaboratoryMetastatic lesions had far higher levels ofMALAT1(pink) than the surrounding tissues. Credit: Spector lab/CSHLWhen researchers look for potential cancer t

Updated on:April 04,2026

Latin American research indicates a lower prevalence of a type of head and neck cancer

by Maria Fernanda Ziegler,FAPESPCredit: Picas Joe from PexelsSquamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common c

Updated on: March 08,2026

Latin American research indicates a lower prevalence of a type of head and neck cancer

by Maria Fernanda Ziegler,FAPESPCredit: Picas Joe from PexelsSquamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth-most common c

Updated on:March 08,2026

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targete

Updated on: March 22,2026

Newly identified lymphoma subtype gives hope in fight against aggressive form of blood cancer

byUniversity of SouthamptonCredit: Unsplash/CC0 Public DomainResearchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targete

Updated on:March 22,2026

Differences persist in cancer mortality burden by where patients live, socioeconomic status, race/ethnicity

byAmerican Cancer SocietySocial determinants of health and cancer disparities. Credit:CA: A Cancer Journal for Clinicians(2025). DOI: 10.3322/caac.70045In new research on the status of cancer disparit

Updated on: February 14,2026

Differences persist in cancer mortality burden by where patients live, socioeconomic status, race/ethnicity

byAmerican Cancer SocietySocial determinants of health and cancer disparities. Credit:CA: A Cancer Journal for Clinicians(2025). DOI: 10.3322/caac.70045In new research on the status of cancer disparit

Updated on:February 14,2026

New Raman imaging system detects subtle tumor signals

byOpticaResearchers developed a sensitive Raman imaging system that can detect very faint signals from SERS nanoparticles that bind to tumor markers. Credit: Zhen Qiu, Michigan State UniversityResearc

Updated on: March 17,2026

New Raman imaging system detects subtle tumor signals

byOpticaResearchers developed a sensitive Raman imaging system that can detect very faint signals from SERS nanoparticles that bind to tumor markers. Credit: Zhen Qiu, Michigan State UniversityResearc

Updated on:March 17,2026

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d

Updated on: April 06,2026

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d

Updated on:April 06,2026

Genomic test helps flag early aggressive prostate cancer in African American patients

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Anna Tarazevich from PexelsA new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men w

Updated on: February 26,2026

Genomic test helps flag early aggressive prostate cancer in African American patients

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Anna Tarazevich from PexelsA new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men w

Updated on:February 26,2026